Sweden In Vitro Diagnostics Quality Control Market Size & Outlook

The in vitro diagnostics quality control market in Sweden is expected to reach a projected revenue of US$ 7.3 million by 2030. A compound annual growth rate of 3.3% is expected of Sweden in vitro diagnostics quality control market from 2024 to 2030.
Revenue, 2023 (US$M)
$5.8
Forecast, 2030 (US$M)
$7.3
CAGR, 2024 - 2030
3.3%
Report Coverage
Sweden

Sweden in vitro diagnostics quality control market, 2018-2030 (US$M)

Sweden

Related Markets

Sweden in vitro diagnostics quality control market highlights

  • The Sweden in vitro diagnostics quality control market generated a revenue of USD 5.8 million in 2023 and is expected to reach USD 7.3 million by 2030.
  • The Sweden market is expected to grow at a CAGR of 3.3% from 2024 to 2030.
  • In terms of segment, controls was the largest revenue generating product in 2023.
  • Calibrators is the most lucrative product segment registering the fastest growth during the forecast period.


In vitro diagnostics quality control market data book summary

Market revenue in 2023USD 5.8 million
Market revenue in 2030USD 7.3 million
Growth rate3.3% (CAGR from 2023 to 2030)
Largest segmentControls
Fastest growing segmentCalibrators
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationControls, Calibrators
Key market players worldwideSiemens Healthineers AG ADR, Abbott Laboratories, Bio-Rad Laboratories Inc, Danaher Corp, Roche Holding AG ADR, Sysmex Corp, QuidelOrtho Corp, Thermo Fisher Scientific Inc, BD, Merck KGaA, Qiagen NV, Hologic Inc, Bio-Techne Corp, Randox, Helena Laboratories, Seracare Life Sciences, Fortress Diagnostics, Microbiologics, TRINA BIOREACTIVES, Cone Bioproducts, Biorex Food Diagnostics


Other key industry trends

  • In terms of revenue, Sweden accounted for 0.5% of the global in vitro diagnostics quality control market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany in vitro diagnostics quality control market is projected to lead the regional market in terms of revenue in 2030.
  • Spain is the fastest growing regional market in Europe and is projected to reach USD 36.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

In Vitro Diagnostics Quality Control Market Scope

In vitro diagnostics quality control market segmentation & scope
Total Protein
Albumin
Blood Urea Nitrogen
Uric Acid
Creatinine
Sodium
Potassium
Chloride
Calcium
Magnesium
Inorganic Phosphorus
Aspartate Transaminase
Creatine Kinase
Gamma Glutamyl transferase
Total Bilirubin
Glucose
Iron
Alanine Transaminase
Alkaline Phosphatase
Alpha Amylase
Total Cholesterol
Triglyceride
Lactate Dehydrogenase
Immunoglobulin G
Immunoglobulin A
Immunoglobulin M
Complement 3
Complement 4
C-Reactive Protein
Rheumatoid Factor
Anti-Streptolysin -O
Beta 2 Micorgloblin
Cystatin-C
Myoglobin
Troponin T and I
Others
Calibrators
Others
Plasma-based Control
Serum-based Control
Whole blood-based Control
Others
Quality Assurance Services
Data Management Solutions
Immunochemistry
Hematology
Alkaline Phosphatase (ALP)
Alanine Transaminase (ALT)
Aspartate Transaminase (AST)
Creatine Kinase MB (CK-MB)
Albumin
Creatinine
Glucose
Triglycerides
Amylase
Others
Molecular Diagnostics
Coagulation
Microbiology
Others
Independent Controls
Instrument Specific Controls
OEM Controls
Hospitals
Laboratories
Home Care
Others

In Vitro Diagnostics Quality Control Market Companies

Name Profile # Employees HQ Website

Sweden in vitro diagnostics quality control market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro diagnostics quality control market will help companies and investors design strategic landscapes.


Controls was the largest segment with a revenue share of 48.28% in 2023. Horizon Databook has segmented the Sweden in vitro diagnostics quality control market based on controls, calibrators covering the revenue growth of each sub-segment from 2018 to 2030.


Sweden has a well-developed healthcare infrastructure with a strong focus on early disease detection and prevention. This is anticipated to potentially drive the demand for quality control in screening and diagnostic procedures. Like many other developed countries, Sweden has been witnessing an increase in the incidence of chronic conditions. 

According to a Swedish Cancer Society Report published in 2023, around 68,810 people were diagnosed with cancer, and by 2040, 100,000 new cancer cases are expected to be detected. This growing patient population may drive the demand for effective diagnostics for early diagnosis and monitoring. 

Sweden’s universal health system covers services such as inpatient, outpatient, diagnostics, and prescription drugs. The health system in the country is decentralized and all residents are covered by healthcare services. 

Reasons to subscribe to Sweden in vitro diagnostics quality control market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Sweden in vitro diagnostics quality control market databook

  • Our clientele includes a mix of in vitro diagnostics quality control market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Sweden in vitro diagnostics quality control market , including forecasts for subscribers. This country databook contains high-level insights into Sweden in vitro diagnostics quality control market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Sweden in vitro diagnostics quality control market size, by product, 2018-2030 (US$M)

Sweden In Vitro Diagnostics Quality Control Market Outlook Share, 2023 & 2030 (US$M)

Sweden in vitro diagnostics quality control market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more